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Summary 
Clonidine, an alpha 2 adrenoreceptor agonist, is used to 
treat opiate dependent individuals who are experiencing the signs 
and symptoms of withdrawal. Changes in the apparent number of 
alpha 2 adrenoreceptors in specific areas of the rat brain have 
been observed after chronic morphine administration. In the 
present study, the effects of chronically administered morphine 
sulfate upon alpha 2 adrenoreceptors were compared to those of 
UM-1072, (+)-5,9-alpha-dimethyl-2-hydroxy-2-tetrahydro-furfuryl- 
6,7-benzomorph-an HCI, a "kappa" agonist which does not produce 
typical morphine-like dependence. The maximum number of specific 
binding sites (Bma x) and dissociation constants (KD'S) for 
3H-clonidine were measured with neural membranes isolated from 
saline or drug-treated rats. Rats were injected with saline, 
morphine or UM-I072, i .p. ,  every 8 hr for 14 days. Doses of 
morphine ranged from lO mg/kg, t . i . d . ,  on the f i r s t  three days to 
lO0 mg/kg, t . i . d . ,  on the last two days. Doses of UM-I072 covered 
a similar range. In control experiments, the Bmax'S for specific 
binding of 3H-clonidine were (in fmoles/mg protein): 
hypothalamus, 142 + 7; amygdala, 141 + 3; brainstem, 70 + 2; 
parietal cortex, 130+ 4; hippocampus, 94-+ 2; and caudate nucTeus, 
62 + 3. After chronic morphine tre~ment, the Bmax'S were 
decreased significantly in all areas except the hippocampus. After 
chronic UM-I072 treatment, the Bmax'S were decreased 
significantly in all areas studied. Neither treatment altered 
appreciably the KD'S for 3H- clonidine. This study suggests 
that "mu" and "kappa" agonists might have similar actions upon 
noradrenergic systems in the brain. 
Neuronal release of norepinephrine is regulated in part by stimulation of 
the alpha 2 adrenoreceptor (1,2). Stimulation of this receptor results in 
inhibition of further norepinephrine release which provides for autoregulation 
of the amount of norepinephrine in the synaptic cleft.  Morphine increases the 
turnover of catecholamines in the rat (3) and mouse brain (4). Tolerance 
develops to this effect of morphine, and during withdrawal, catecholamine 
turnover is reduced in the brains of dependent animals (5). These changes in 
catecholamine turnover might be related to changes in the function of alpha 2 
adrenoreceptors. 
Recently, implantation of morphine pellets for three days was reported to 
increase the apparent number of alpha 2 adrenoreceptors in rat cerebral 
cortex and brainstem (6). In addition, clonidine, a drug which acts upon 
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alpha 2 adrenoreceptors, has been used to treat dependent patients who are 
undergoing opiate withdrawal (7,8). Such findings have been interpreted as 
evidence for a role of alpha 2 adrenoreceptors in opiate dependence. The 
purpose of the present study was to compare the effects of chronically 
administered morphine sulfate to those of UM-1072, a "kappa" agonist, upon 
alpha 2 adrenoreceptors in specific areas of the rat brain. UM-1072 produces 
a form of dependence when administered chronically to experimental animals 
which is not l ike that produced by morphine. 
Mater ia ls  and Methods 
Homogenates were made from the fo l lowing brain areas iso la ted from male 
Sprague-Dawley rats  (220-240 g): amygdala, hippocampus, hypothalamus, 
brainstem, pa r ie ta l  cortex and caudate nucleus. The rats  were in jected with 
sa l ine ,  morphine su l f a te ,  or UM-I072, i . p . ,  every 8 hr fo r  14 days. Morphine 
su l f a te  was in jected i . p .  every 8 hr according to the fo l lowing schedule 
(doses are given per i n j e c t i o n ) :  day I -3 ,  I0 mg/kg; day 4-6, 20 mg/kg; day 
7-9, 40 mg/kg; day 10-12, 70 mg/kg; day 13-14, I00 mg/kg. UM-I072 was 
in jected according to the same schedule except that  the dose was not increased 
above 40 mg/kg per i n jec t ion  a f t e r  day 9. The rats  were k i l l e d  by 
decapi tat ion 8 hr a f te r  the las t  i n j ec t i on .  The various areas of the ra t  
brain were i d e n t i f i e d  h i s t o l o g i c a l l y .  The area which is referred to as thc 
brainstem consisted of a section of brainstem 1 mm th ick which was medial and 
i n f e r i o r  to the superior cerebe l la r  peduncle, superior to the nucleus of the 
Vth cran ia l  nerve, and which contained the mesencephalic nucleus of the 
t r igeminal  nerve as wel l  as the locus coeruleus. The brain areas iso la ted 
from s ix  rats  were pooled fo r  each experiment. The brain areas were 
homogenized in 5 ml of ice-co ld  Tr is-sucrose buf fer  which consisted of 5 mM 
Tr is  (hydroxymethyl) aminomethane, 0.25 M sucrose and 1 mM MgCI2.6H20 
adjusted to pH 7.4 with 1 N HCI. The homogenates were centr i fuged at I000 x g 
for  1 min and the supernates were saved and re-cent r i fuged at 40,000 x g. The 
crude membrane p e l l e t  was washed twice with ice-cold Tr is - incubat ion  bu f fe r ,  
and recentr i fuged at 40,000 x g. The incubation buf fer  was composed of 50 mM 
Tr is  (hydroxymethyl) aminomethane and I0 mM MgCI2.6H20 adjusted to pH 7.5 
with 6 N HCI. The f i n a l  p e l l e t  was resuspended in Tr is - incubat ion  bu f fe r .  To 
measure t o ta l  binding, 1 ml a l iquots  of the neural membranes were incubated in 
dup l ica te  fo r  30 min at 25 ° C with concentrat ions of 3H-clonidine (sp. act.  
22.2 Ci/mmol, NEN, Boston, Mass.) which ranged from 10 -9 M to 6.4 x 10 -8 
M. Nonspecif ic binding was determined by adding unlabeled c lon id ine ,  10 -5 
M, as well as 3H-clonidine to a second pa i r  of incubates. The incubations 
were terminated by rapid f i l t r a t i o n  under vacuum through Whatman GF/C glass 
f i b e r  f i l t e r s  and by washing with two I0 ml a l iquots  of Tr is - incubat ion  buf fer  
at 25 ° C. Results are expressed as fmoles of 3H-clonidine s p e c i f i c a l l y  
bound per mg of pro te in .  
Results 
The distribution of specific binding of 3H-clonidine to neural 
membranes isolated from various areas of the rat brain was uneven (Table I) .  
The greatest number of binding sites was found with membranes from the 
hypothalamus and amygdala, and the lowest number was found with brainstem and 
caudate nucleus membranes. Nonspecific binding ranged from 6% in the amygdala 
to 18% in the caudate nucleus. Neither morphine nor UM-I072 altered 
nonspecific binding to membranes isolated from any of the brain areas. 
Scatchard analyses indicated that only a single population of binding sites 
was present upon the isolated membranes (Figure l ) .  The dissociation 
constants (KD'S) did not d i f fer  signif icantly among the various areas. 
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FIG, 1 
Effects of chronically administered morphine sulfate and UM-1072 upon 
alpha 2 adrenoreceptors on neural membranes isolated from rat parietal 
cortex. Left g raph,  Saturation isotherms: ordinate, 3H-clonidine 
specifically bound; abscissa, concentration of free 3H-clonidine. Right 
graph. Scatchard plots: ordinate, 3H-clonidine specifically bound~free 
H-clonidine in incubate; abscissa, 3H-clonidine specifically bound. 
Solid circles, saline controls; solid triangles, morphine-treated rats; solid 
squares, UM-lO72-treated rats. Shown are representative experiments. 
TABLE I 
Maximum Specific Binding (Bmax) of 3H-Clonidine to Neural Membranes 
Isolated from Rats Treated Chronically with Morphine or UM-I072 
Brain Area Control Morphine UM-I072 
Hypothalamus 142. l  + 7 .3*  112.3 + ]4 .8  702.2 + 6.7 
Amygdala 140.6 ¥ 2.8 111.2 ¥ 6.5 108.2 • 15.4 
P a r i e t a l  Cortex 129.8 ¥ 4.2 103.4 ¥ 0.7 95.8 ¥ 8.6 
Hippocampus 93.7 ¥ 2.1 71.4 ¥ 7.2 69.2 ¥ 3.2 
Brainstem 70.I ¥ 1.5 61.2 ¥ 3.8 62.9 ¥ 3.6 
Caudate Nucleus 62.4 ¥ 3.0 3].7 ¥ 2.5 44.9 ¥ 6.8 
* Each value represents the mean of 3-6 determinations + S.E.M. 
Administration of morphine sulfate for two weeks resulted in 
significant decreases in the maximum number of specific binding sites for 
3H-clonidine in membranes isolated from the hypothalamus (21%, P .05); 
amygdala (21%, P .025); parietal cortex (20%, P .025); brainstem (13%, 
P .05) and caudate nucleus (49%, P .0005). UM-1072 caused decreases in the 
number of binding sites in all areas of the brain studied, These decreases 
were: hypothalamus (28%, P .Ol); amygdala (23%, P .025); parietal cortex 
(26%, P .005); hippocampus (26%, P .0005); brainstem (I0%, P .025) and 
caudate nucleus (28%, P .05). Neither drug caused appreciable changes in 
the KD'S for the specific binding of 3H-clonidine to neural membranes 
isolated from the various brain areas. 
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Discussion 
Long-term administration of both morphine su l fa te,  a "mu" agonist, and 
UM-I072, a "kappa" agonist, decreased the maximum number of alpha 2 
adrenoreceptors in speci f ic  areas of the rat brain. The present study is not 
in agreement with that of Hamburg and Tallman (6); however, there were 
s ign i f i can t  procedural di f ferences between the two studies which include route 
and duration of drug administrat ion. A number of studies have shown that 
opiates increase the turnover of catecholamines in the brain (3-5).  Thus, the 
observed changes in alpha 2 adrenoreceptors might be secondary to increases 
in neuronal norepinephrine turnover. Other drugs and procedures which are 
thought to increase synaptic norepinephrine levels also cause decreases in the 
number of alpha 2 adrenoreceptors on neural membranes isolated from certain 
areas of the rat  brain. These include chronical ly  administered amitrypty l ine 
(9), a t r i c y c l i c  antidepressant, chronica l ly  administered chlorgy l ine ( I0 ) ,  a 
monoamine oxidase inh ib i to r ,  and repeated electroshock treatment ( I I ) .  
Changes in catecholamine turnover in brain have been related to the dependence 
produced by opiates (12). I f  the changes in receptor number in the present 
study re f l ec t  changes in catecholamine turnover, the fact  that both a "mu" and 
"kappa" agonist cause the same changes in receptor number might lead to a 
reassessment of the re la t ionship of noradrenergic mechanisms to opiate-induced 
dependence. 
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